Menu

RWEpi
Real World Epidemiology Research Group (RWEpi)

Group leader
avatar_investigadors.jpg
Talita Duarte Salles
avatar_grups_recerca.png

Projects

Group projects

Drug Utilization Study (DUS) and Post Authorization Safety Study (PASS) on the fixed combination tramadol-dexketoprofen (DKP-TRAM)

  • Principal investigators: Talita Duarte Salles
  • Code: 4R21/004
  • Start year: 2021
  • Funders: SIMG SERVICE CONGRESS AND EDUCATION S.R.L, SIMG – Società Italiana di Medicina Generale e delle cure primarie

Risk of mental and behavioral disorders in relation to availability of green spaces

  • Principal investigators: Talita Duarte Salles
  • Code: 4R21/017
  • Start year: 2021
  • Funders: Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)

The descriptive epidemiology of Adverse Events of Special Interest for COVID-19 and other vaccines and after seasonal influenza and COVID-19 disease in SIDIAP

  • Principal investigators: Daniel Prieto Alhambra, Talita Duarte Salles
  • Code: 4R21/018
  • Start year: 2021
  • Funders: Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)

Systemic glucocorticoids in the treatment of COVID-19 and risks of adverse outcomes in COVID-19 patients in the primary and secondary care setting

  • Principal investigators: Talita Duarte Salles
  • Code: 4R21/019
  • Start year: 2021
  • Funders: IQVIA Solutions BV

Impact of EU label changes fluoroquinolone containing medicinal products for systemic and inhalation use: post-referral prescribing trends

  • Principal investigators: Talita Duarte Salles
  • Code: 4R21/020
  • Start year: 2021
  • Funders: IQVIA Solutions BV

Board of Trustees

Collaborators

Accreditations